Fibrin formation disorders. Technic of evaluation of the first stage
Soria, J.; Soria, C.; Girard, M.L.; Samama, M.
Pathologie-Biologie 20(5): 315-321
1972
ISSN/ISBN: 0369-8114 PMID: 4113775 Document Number: 46418
Document emailed within 1 workday
Related Documents
Mironov, G.P.; Molchanova, L.V. 1971: SH--SS transition reactions during fibrin formation Voprosy Meditsinskoi Khimii 17(3): 301-306Dolesobel, W. 1972: Use of new methods for studies of blood coagulation. II. Clot-sedimentation-technic for the determination of antithrombin i effect of fibrin Wiener Medizinische Wochenschrift 122(41): 585-590
Deykin, D.; Silversmith, P.; Ashford, T. 1970: A serum-induced defect in fibrin formation Journal of Laboratory and Clinical Medicine 76(5): 761-774
Yakovlev, S.A.; Makogonenko, E.M.; Druzhina, N.N.; Cederholm-Williams, S.A. 1996: Formation and dissolution of fibrin in model systems Ukrainskii Biokhimicheskii Zhurnal 68(4): 24-25
Juhlin, L.; Michaëlsson, G. 1983: Fibrin microclot formation in patients with acne Acta Dermato-Venereologica 63(6): 538-540
Davey, F.R.; Gordon, G.B.; Boral, L.I.; Gottlieb, A.J. 1976: Gamma globulin inhibition of fibrin clot formation Annals of Clinical and Laboratory Science 6(1): 72-77
Thabaut, A.; Laverdant, C.; Durosoir, J.L.; Cristau, P.; Essioux, J.; Molinié, C. 1979: Abnormalities of fibrin formation in benign viral hepatitis Annales de Medecine Interne 130(1): 35-38
Bruzgo, I.; Midura-Nowaczek, K.; Bruzgo, M.; Kaczyńska, J.; Roszkowska-Jakimiec, W.ła. 2006: Effect of epsilon-aminocaproylamino acids on fibrin formation Acta Poloniae Pharmaceutica 63(2): 149-152
Rysavá, J.; Másová, L.; Dyr, J.E.; Suttnar, J.; Salaj, P.; Dostálek, J.; Myska, K.; Pecka, M. 2002: Effect of oxidized cellulose on fibrin formation and blood platelets Casopis Lekaru Ceskych 141 Suppl: 50-53
Byshevskiĭ, A.S.; Chiriat'ev, E.A.; Umutbaeva, M.K.; Tazhudinova, S.I. 1986: Regulator peptide of blood aggregation function at the stage of fibrin self-assembly Gematologiia i Transfuziologiia 31(6): 26-31
Vorlová, Z.; Dyr, I.E. 1979: Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test) Folia Haematologica 106(5-6): 967-970
Ball, A.P.; McKee, P.A. 1977: Fibrin formation and dissolution in women receiving oral contraceptive drugs Journal of Laboratory and Clinical Medicine 89(4): 751-762
Bärtsch, P.; Haeberli, A.; Straub, P.W. 1990: Blood coagulation after long distance running: antithrombin III prevents fibrin formation Thrombosis and Haemostasis 63(3): 430-434
Marchi, R.; Maya, I.; Garmendia, J. 2011: Effect of antiphospholipid antibodies on the formation and lysis of fibrin network in patients with recurrent miscarriage Investigacion Clinica 52(1): 35-47
Ishmukhametova, D.N.; Mozhina, A.A. 1984: Relation of the formation of the fibrin network of a blood clot to the amount of thrombin in complexes with endogenous heparin Anesteziologiia i Reanimatologiia 2: 30-34
Ito, S.; Sugisaki, T.; Soezima, K. 1989: Generation of oxygen radicals and formation of fibrin thrombi in glomerular capillaries of rats with nephrotoxic nephritis Nihon Jinzo Gakkai Shi 31(2): 171-177
Solov'ev, A.V.; Ermolin, G.A.; Ignashenkova, G.V.; Dikov, M.M. 1987: Fibrinogen and fibrin degradation products in the blood of acute myocardial infarct patients at the hospital rehabilitation stage Terapevticheskii Arkhiv 59(10): 21-23
Soulat, T.; Loyau, S.; Baudouin, V.; Durlach, V.; Gillery, P.; Garnotel, R.; Loirat, C.; Anglés-Cano, E. 1999: Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin--a study with individual plasmas presenting natural variations of Lp(a) Thrombosis and Haemostasis 82(1): 121-127
Oda, M.; Kanamori, T.; Marukawa, Y.; Itoh, Y.; Ishikawa, N.; Tamura, M.; Go, T.; Watanabe, S.; Ohta, Y.; Watanabe, G.; Watanabe, Y. 2000: Evaluation of new TNM classification for lung cancer, especially T3N0M0, stage IIIA, stage IIIB, and pm Kyobu Geka. Japanese Journal of Thoracic Surgery 53(11): 905-909
Koga, S. 2004: A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF) Rinsho Byori. Japanese Journal of Clinical Pathology 52(4): 355-361